Home MolMed a new patent on its anticancer NGR-hTNF
 

Keywords :   


MolMed a new patent on its anticancer NGR-hTNF

2013-09-11 20:07:47| Logistics - Topix.net

MolMed S.p.A. announces today receipt of the official notification from the European Patent Office of the decision to grant a patent covering the therapeutic use of its investigational anticancer drug NGR-hTNF at low doses.

Tags: patent anticancer

Category:Transportation and Logistics

Latest from this category

All news

24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »